Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP

This study has been completed.
Sponsor:
Collaborators:
Qualitix Clinical Research Co., Ltd.
Parexel
PPD
Information provided by (Responsible Party):
TaiGen Biotechnology Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01529476
First received: January 31, 2012
Last updated: June 17, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)